GARY PATOU

Insider Reports History

Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GARY PATOU:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 23,573 $967,672 $41.05 22 Nov 2024 Direct
Xenon Pharmaceuticals Inc. Director Common Shares 4,902 $201,227 $41.05 22 Nov 2024 Indirect
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17,012 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2,645 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 22 Nov 2024 Direct

Insider Reports Filed by GARY PATOU

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 18:00
XENE Xenon Pharmaceuticals Inc. 22 Nov 2024 8 -$200,978 4 Director 22 Nov 2024, 19:48
XENE Xenon Pharmaceuticals Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 17:43
XENE Xenon Pharmaceuticals Inc. 13 Dec 2023 1 -$311,898 4/A Director 15 Dec 2023, 21:50
XENE Xenon Pharmaceuticals Inc. 02 Jun 2023 1 $0 4 Director 02 Jun 2023, 17:27
XENE Xenon Pharmaceuticals Inc. 23 Nov 2022 5 -$136,612 4 Director 28 Nov 2022, 19:41
XENE Xenon Pharmaceuticals Inc. 28 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:40
XENE Xenon Pharmaceuticals Inc. 08 Dec 2021 2 +$7,549 4 Director 10 Dec 2021, 15:20
XENE Xenon Pharmaceuticals Inc. 17 Mar 2021 2 +$1,949 4 Director 04 Jun 2021, 19:20